Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Orlando, Mauro
1089  Ergebnisse:
Personensuche X
?
1

Clinical Trial Protocol for ROSELLA: a phase 3 study of rel..:

Olawaiye, Alexander B. ; Kim, Jae-Weon ; Bagameri, Andrea...
Journal of Gynecologic Oncology.  35 (2024)  4 - p. , 2024
Link: https://doi.org/10.3802/..
 
?
2

Cisplatino y gemcitabina concurrente con radioterapia en cá..:

Pérez, Juan Felipe ; Blanco, Albano ; Enrico, Diego...
Oncología Clínica.  28 (2023)  2 - p. , 2023
Link: https://doi.org/10.56969..
 
?
3

A Randomized Phase 2 Study of Gefitinib With or Without Pem..:

Yang, James Chih-Hsin ; Cheng, Ying ; Murakami, Haruyasu...
Journal of Thoracic Oncology.  15 (2020)  1 - p. 91-100 , 2020
Link: https://doi.org/10.1016/..
 
?
4

Ramucirumab in patients with advanced gastric and gastroeso..:

Yen, Chia-Jui ; Bai, Li-Yuan ; Cheng, Rebecca..
Journal of Cancer Research and Practice.  5 (2018)  2 - p. 43-46 , 2018
Link: https://doi.org/10.1016/..
 
?
5

Dynamic change of fatigue of pemetrexed maintenance treatme..:

Zhang, Li ; Belani, Chandra P. ; Zhang, Ping-hai...
Lung Cancer.  115 (2018)  - p. 121-126 , 2018
Link: https://doi.org/10.1016/..
 
?
6

Subgroup analysis of East Asian patients in REGARD: A phase..:

Chung, Hyun Cheol ; Kok, Victor C. ; Cheng, Rebecca...
Asia-Pacific Journal of Clinical Oncology.  14 (2018)  3 - p. 204-209 , 2018
Link: https://doi.org/10.1111/..
 
?
7

Ramucirumab Safety in East Asian Patients: A Meta-Analysis ..:

Yen, Chia-Jui ; Muro, Kei ; Kim, Tae-Won...
Journal of Global Oncology.  , 2018
Link: https://doi.org/10.1200/..
 
?
8

A Review of Regimens Combining Pemetrexed With an Epidermal..:

Yang, James Chih-Hsin ; Mok, Tony ; Han, Baohui...
Clinical Lung Cancer.  19 (2018)  1 - p. 27-34 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Age does not influence efficacy of ramucirumab in advanced ..:

Muro, Kei ; Cho, Jae Yong ; Bodoky, Gyorgy...
Journal of Gastroenterology and Hepatology.  33 (2018)  4 - p. 814-824 , 2018
Link: https://doi.org/10.1111/..
 
?
10

Anti-angiogenic Therapy in Patients with Advanced Gastric a..:

Chen, Li-Tzong ; Oh, Do-Youn ; Ryu, Min-Hee...
Cancer Research and Treatment.  49 (2017)  4 - p. 851-868 , 2017
Link: https://doi.org/10.4143/..
 
?
11

Efficacy and Safety of First-Line Necitumumab Plus Gemcitab..:

Park, Keunchil ; Cho, Eun Kyung ; Bello, Maximino...
Cancer Research and Treatment.  49 (2017)  4 - p. 937-946 , 2017
Link: https://doi.org/10.4143/..
 
?
12

Exposure–response relationship of ramucirumab in East Asian..:

Kim, Tae You ; Yen, Chia-Jui ; Al-Batran, Salah-Eddin...
Gastric Cancer.  21 (2017)  2 - p. 276-284 , 2017
Link: https://doi.org/10.1007/..
 
?
13

An East Asian subgroup analysis of PROCLAIM, a phase III tr..:

Wang, Luhua ; Wu, Yi‐Long ; Lu, Shun...
Asia-Pacific Journal of Clinical Oncology.  12 (2016)  4 - p. 380-387 , 2016
Link: https://doi.org/10.1111/..
 
?
14

Second-line ramucirumab therapy for advanced hepatocellular..:

Park, Joon Oh ; Ryoo, Baek-Yeol ; Yen, Chia-Jui...
Oncotarget.  7 (2016)  46 - p. 75482-75491 , 2016
Link: https://doi.org/10.18632..
 
?
15

Tolerability and Outcomes of First-Line Pemetrexed-Cisplati..:

Kang, Jin Hyoung ; Ahn, Myung-Ju ; Kim, Dong-Wan...
Cancer Research and Treatment.  48 (2016)  2 - p. 458-464 , 2016
Link: https://doi.org/10.4143/..
 
1-15